Kari R. Irvine
- Immunology top 0.5%
- Molecular Biology top 5%
- Oncology top 2%
- Genetics top 2%
- Epidemiology top 5%
- Co-authors
- Nicholas P. RestifoSteven A. RosenbergBernard MossMiles W. CarrollBrian H. BarberRonald N. GermainAkiko IwasakiAngel Porgador
- Topics
- Immunotherapy and Immune Responses (26 papers)Virus-based gene therapy research (13 papers)T-cell and B-cell Immunology (9 papers)
- Cited by
- ImmunologyVirologyOncology
- Journals
- Proceedings of the National Academy of SciencesNature MedicineThe Journal of Experimental Medicine
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Kari R. Irvine
33 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Immunology 3.2k
- Molecular Biology 1.4k
- Oncology 1.1k
- Genetics 713
- Epidemiology 492
Countries citing papers authored by Kari R. Irvine
This map shows the geographic impact of Kari R. Irvine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari R. Irvine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari R. Irvine more than expected).
Fields of papers citing papers by Kari R. Irvine
This network shows the impact of papers produced by Kari R. Irvine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari R. Irvine. The network helps show where Kari R. Irvine may publish in the future.
Co-authorship network of co-authors of Kari R. Irvine
This figure shows the co-authorship network connecting the top 25 collaborators of Kari R. Irvine. A scholar is included among the top collaborators of Kari R. Irvine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari R. Irvine. Kari R. Irvine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | Tumor-specific Th17-polarized cells eradicate large established melanomabreakdown → | 638 |
| 3 | 25 | |
| 4 | 120 | |
| 5 | 90 | |
| 6 | 260 | |
| 7 | 269 | |
| 8 | 51 | |
| 9 | 2 | |
| 10 | 12 | |
| 11 | 129 | |
| 12 | 15 | |
| 13 | 115 | |
| 14 | 203 | |
| 15 | 37 | |
| 16 | 194 | |
| 17 | 10 | |
| 18 | 170 | |
| 19 | Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate. | 69 |
| 20 | 22 |
About Kari R. Irvine
Kari R. Irvine is a scholar working on Virology, Immunology and Genetics, having authored 33 papers that have together received 4.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (26 papers), Virus-based gene therapy research (13 papers) and T-cell and B-cell Immunology (9 papers). The work is most often cited by research in Immunology (3.2k citations), Virology (371 citations) and Oncology (1.1k citations). Kari R. Irvine has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Nicholas P. Restifo, Steven A. Rosenberg, Bernard Moss, Miles W. Carroll, Brian H. Barber, Ronald N. Germain, Akiko Iwasaki, Angel Porgador, Jack R. Bennink and Christopher E. Touloukian. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.